Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic immunization against anthrax.

Darrell Galloway1, Adriane Liner, Joseph Legutki

  • 1Department of Microbiology, The Ohio State University, 484 West 12th Avenue, Columbus, OH 43210, USA. gallowayd@nmrc.navy.mil

Vaccine
|April 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model.

Toxins·2021
Same author

Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.

Clinical and vaccine immunology : CVI·2015
Same author

Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.

Pathogens and disease·2014
Same author

Genetic variation and linkage disequilibrium in Bacillus anthracis.

Scientific reports·2012
Same author

Cynomolgus macaque model for pneumonic plague.

Microbial pathogenesis·2010
Same author

Rapid identification of genetic modifications in Bacillus anthracis using whole genome draft sequences generated by 454 pyrosequencing.

PloS one·2010
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

DNA prime-protein boost immunization against Bacillus anthracis protective antigen (PA) and lethal factor (LF) induced significant protective immunity in rabbits. This DNA-based strategy compared favorably to traditional protein immunization against anthrax.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Bacillus anthracis infection poses a significant biothreat.
  • Effective vaccines are crucial for anthrax prevention.
  • Developing novel immunization strategies is essential.

Purpose of the Study:

  • To evaluate DNA prime-protein boost immunization efficacy against Bacillus anthracis.
  • To assess immune response to protective antigen (PA) and lethal factor (LF) antigens.
  • To compare DNA-based vaccines with protein-based immunization in a rabbit model.

Main Methods:

  • Rabbits received different DNA vaccine regimens.
  • Animals were aerosol challenged with B. anthracis spores (Ames strain).
  • Antibody responses to PA were measured by ELISA.

Related Experiment Videos

Main Results:

  • DNA prime-protein boost immunization conferred protective immunity against aerosol challenge.
  • Survival was linked to sustained antibody responses to PA.
  • DNA-based immunization showed comparable efficacy to protein-based immunization.

Conclusions:

  • DNA-based immunization is a viable strategy for Bacillus anthracis protection.
  • The DNA prime-protein boost approach elicits a robust immune response.
  • This study supports the development of DNA vaccines for anthrax.